Heikkila et al identified risk factors for end-stage renal disease (ESRD) in a patient treated for posterior urethral valves (PUV). These can help to identify a patient who may benefit from more aggressive management. The authors are from Hyvinkaa Hospital, Children’s Hospital, and University of Helsinki in Finland.
